Radiopharmaceutical pylarify FSS BPA - base year delivery order
Ended Awarded
- Contract number
- 36C25026N0037
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,082,616
Award facts
- Contract value 100% obligated
- $1,082,616.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
This is a Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract is for the delivery of the radiopharmaceutical product PYLARIFY, which is used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has a ceiling value of $1,082,616.00 and a period of performance through September 30, 2026. This is not a set-aside contract. Lantheus Holdings, Inc. is the parent company of the prime contractor, Progenics Pharmaceuticals Inc., and holds several significant Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency for the provision of PYLARIFY and other specialized medical imaging products to federal healthcare providers.
Quick answers
Who was awarded contract 36C25026N0037?
36C25026N0037 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C25026N0037 worth?
The government has obligated $1,082,616 on 36C25026N0037.
Is contract 36C25026N0037 an order under another contract?
Yes. 36C25026N0037 is a BPA call under 36F79725D0093-36C25026A0002, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25026N0037 competed?
The extent of competition for 36C25026N0037 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award